LY686017

DRUG3 trials

Sponsors

Eli Lilly and Company, National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Conditions

Alcohol DependenceAlcoholismSocial Phobia

Phase 2

Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder

CompletedNCT00191022

Eli Lilly and CompanySocial Phobia

Start: 2004-12-31End: 2007-01-31Target: 185Updated: 2007-02-13

Effect of LY686017 on Alcohol Craving

CompletedNCT00310427

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Alcohol Dependence, Alcoholism

Start: 2006-03-31End: 2008-03-31Updated: 2010-04-20

A Study in the Treatment of Alcohol Dependence.

CompletedNCT00805441

Eli Lilly and CompanyAlcohol Dependence

Start: 2008-12-31End: 2009-07-31Updated: 2019-09-17